Clinical trial
The Optimal Dosage of Intrathecal Morphine for Peripartum Analgesia
NCT01146457 is registered in ClinicalTrials.gov with Beth Israel Deaconess Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Optimal Dosage of Intrathecal Morphine for Peripartum Analgesia
- Lead sponsor
- Beth Israel Deaconess Medical Center
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- July 31, 2010
- Completion date
- January 31, 2015
- Enrollment
- 83 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.